A nasal spray that contains esketamine — a potent derivative of ketamine — can now be taken on its own to treat adults with ...

The symptoms of mental health disorders and chronic pain affect every facet of life, especially during the dark, cold days of ...

The U.S. Food and Drug Administration expanded approval for Johnson & Johnson’s nasal spray, Spravato, to allow it to be used ...

CIII allows people who have tried at least two oral antidepressants to use the spray on its own – without the need for more ...

People with treatment-resistant depression can now take Spravato's ketamine-derived nasal spray as a standalone treatment.

Johnson & Johnson's ketamine-derived nasal spray has been approved as a standalone treatment to fight depression for those ...

A clinic in Arapahoe County is exploring new ways to help patients by offering ketamine-assisted psychotherapy.

Here's what MDs want you to know about Spravato, the latest FDA-approved standalone nasal spray for depression.

A new study has found small amounts of liquid ketamine administered in a clinical setting can significantly reduce symptoms ...